GENERIC NAME

CLASSIFICATION Laxatives

INDICATION -Constipation -To prevent and treat hepatic encephalopathy, including hepatic precoma and coma in patients with severe hepatic disease. -to induce bowel evacuation after a barium meal examination -to restore bowel movements after hemorrhoidectomy

ACTION The drug passes unchanged into the colon here bacteria breaks it down into organic acids that increase the osmotic pressure in the colon and slightly acidify the colonic contents, stool softening , and laxative actions. -Relieves constipation - Decrease blood ammonia concentration

LACTULOSE
(Enuluse, Kristalose, Duphalac, Chronulac Syrup)
Duphalac, Cephulac, Cholac, Chronulac, Constulose, Enulose, Generlac, Kristalose

SPECIAL PRECAUTION Patients with Diabetes and Pregnant women -patients with diabetes mellitus -pregnant women -breastfeeding women -elderly patients (more susceptible to hyponatremia)

CONTRANDICATION Hypersensitivity to lactulose and low galactose diet. -low-galactose diet (patients) -children with chronic constipation

SIDE EFFECTS -Nausea and Vomiting -Abdominal cramps -Gas -Borborygmus -Flatulence -Abdominal cramps, belching, diarrhea, distention, flatulence Adverse Reaction: Nausea, vomiting

DOSAGE AND AVAILABILITY
Dosage Oral: Infants: 2.5-10 mL/day divided into 3-4 times/day; adjust dosage to produce 2-3 stools/day. Older Children: Daily dose of 40-90mL divided to 3-4 times/day; if initial dose causes diarrhea then reduce it immediately; adjust dosage to produce 2-3 stools/day. Constipation Oral Children: 5g/day (7.5mL) after breakfast Adult: 15-30 mL/day increased to 60 mL/day in 1-2 divided doses if necessary. Acute PSE: Oral: Adult: 20-30g (30-45mL) every 1-2 hours to induce rapid laxation; adjust dosage daily to produce 23 soft stools; doses of 30-45mL may be given hourly to cause rapid laxation, then reduce to recommended dose; usual daily dose: 60-100g (90-150mL) daily. Rectal Administration: 200g (300mL) diluted with 700mL to H2O or NS; administer rectally via rectal balloon catheter and retain 30-60 minutes every 4-6 hours. Availability: Medicine is available as crystals and as liquids.

NURSING RESPONSIBILITIES Monitor periodically for electrolytes imbalance when lactulose is used >6 months or in patients predisposed to electrolyte abnormalities (eg, elderly); patients receiving lactulose and an oral antiinfective agent should be monitored for possible inadequate response to lactulose.

GENERIC NAME

CLASSIFICATION H2-receptor antagonists (Histamine blocker) Anti-ulcerative

INDICATION -Active duodenal and gastric ulcer. -Gastroesophageal reflux disease -pathologic hypersecretory conditions (ZES) -Erosive esophagitis -Heartburn -duodenal and gastric ulcer -maintenance therapy for duodenal ulcer -gastroesophageal reflux dse. -erosive esophagitis -for occasional heartburn, acid ingestion & sour stomach

ACTION Prevents the secretion of acid into the stomach. Inhibits action of H2 at receptor sites of parietal cells, decreasing gastric acid dysfunction.

RANITIDINE
(Tritec, Zantac, Zantac75, Zantac EFFERdose, Zantac Premixed, Zantac Syrup)

SPECIAL PRECAUTION Porphyria, Phenylketonuria, or kidney or liver diseases before pregnancy or lactation. -patients with hepatic dysfunction -pregnant women -breastfeeding mother/women

CONTRANDICATION Contraindicated with allergy to ranitidine, lactation.

SIDE EFFECTS Agitation, Nervousness, Hallucinations, Constipation or diarrhea, dark yellow or Brown urine, dizziness, headache, nausea, vomiting, redness, blistering, peeling or loosening of the skin, including the mouth, skin rash, itching, sore throat, fever, stomach pain, unusual weakness or tiredness, unusual bleeding or bruising, yellowing of the skin or eyes.

DOSAGE AND AVAILABILITY Dosage Adult: 150mg P.O. bid.

Children: (1mo-16 yrs.old)) For duodenal and gastric ulcers only; 24mg/kg P.O. b.i.d.,up to 300mg/day. Availability; Tablet, an effervescent tablet, effervescent granules, and syrup.

NURSING RESPONSIBILITIES -Assess patient for abdominal pain. -Note presence of blood in emesis, stool or gastric aspirate. -Drug may be added to total parenteral nutrition solutions.

GENERIC NAME

CLASSIFICATION Diuretics, Osmotic, Sweetening Agent

INDICATION -Test dose for market oliguria or suspected inadequate renal function. -Oliguria -To prevent oliguria or acute renal failure -To reduce intracellular or intracranial pressure. -Diuresis in drug intoxication.

ACTION Increases the osmotic pressure of glomerular filtrate, which inhibits tubular reabsorption of water and electrolytes and increases urinary output.

MANNITOL
(Osmitrol)

SPECIAL PRECAUTION Should not be administered until adequacy of renal function and urine flow is established.

CONTRANDICATION Hypersensitivity to mannitol or any component or the formulation; severe renal disease (anuria); dehydration, active intracranial bleeding, severe pulmonary edema or congestion. Those with anuria, pulmonary edema, severe dehydration, progressive heart failure or pulmonary congestion after mannitol therapy.

SIDE EFFECTS CNS: headache, convulsions, headache, chills, dizziness Dermatologic: Rash Endocrine & Metabolic: Fluid and electrolyte imbalance, water intoxication, dehydration, hypovolemia secondary to rapid diuresis, hyponatremia, Genitourinary: Polyuria, Dysuria Local: Tissue necrosis Ocular: Blurred Vision Respiratory: Pulmonary edema Miscellaneous: Allergic reaction

DOSAGE AND AVAILABILITY Dosage Adult: and children older than 12 years old: 500-100g I.V. as 15%25% solution over 90 minutes to several hours. Availability Injection, Solution

NURSING RESPONSIBILITIES Cardiovascular status should also be evaluated; do not administer electrolyte-free mannitol solutions with blood. -Asses patient s condition before therapy and regularly thereafter to monitor the drug s effectiveness. -Monitor vital signs, central venous pressure and fluid intake & output hourly. -Insert urethral catheter in comatose or incontinent patient because therapy is based on strict evaluation of fluid intake & output.

titrates to desired response.V. large doses stimulate alphaadrenergic receptors. anxiety GI: Nausea. Obtain history of patient s underlying condition before therapy. -To improve perfusion to vital organs. desired response. Neonates: 1-20mcg/kg/min. -To increase cardiac output. -During infusion. ACTION Stimulates both adrenergic and dopaminergic receptors. dyspnea Skin: necrosis DOSAGE AND AVAILABILITY Dosage I. DOPAMINE (Intropin) SPECIAL PRECAUTION Use with caution in patients with cardiovascular disease or cardiac arrhythmias or patients with occlusive vascular disease. frequently monitor ECG. titrate to desired response. infusion (administration requires the use of an infusion pump). Metabolic: Azolemia. a more direct-acting pressure may be more beneficial (ie. If dosage >20-30 mcg/kg/minute are needed. use with caution in post-MI patients. hyperglycemia Respiratory: Asthmatic episodes. blood pressure and cardiac output. continuous infusion. epinephrine. Adults: 1-5 mcg/kg/min up to 20 mcg/kg/min. maximum of 50 mcg/kg/min continuous infusion. Infusion may be increased by 1-4 mcg/kg/min at 10 to 30 minute intervals until optimal response is obtained. pheochromocytoma. ventricular fibrillation SIDE EFFECTS CNS: Headache. -Must be diluted before use . -To correct hypotension. Children: 1-20mcg/kg/min. CONTRANDICATION Hypersensitivity to sulfites (commercial preparation contains sodium bisulfite). NURSING RESPONSIBILITIES Hypovolemia and electrolytes when used in hemodynamic support. higher doses also are both dopaminergic and betal-adrenergic stimulating and produce cardiac stimulation and renal vasodilation. vomiting. norepinephrine).GENERIC NAME CLASSIFICATION Adrenergies INDICATION -To treat shock and correct hemodynamic imbalances. lower doses are mainly dopaminergic stimulating and produce renal and mesenteric vasodilation.

blood in urine or stools. ACTION Blocks the ADP receptors.Reduce atherosclerotic events in patients with acute coronary syndrome. tarry stools. Clopidogrel Bisulfate Oral tablets Dosage: Adults: 75 mg P. trauma. CLOPIDOGRIL (Plavix) SPECIAL PRECAUTION Use with caution in patients who may be at risk of increased bleeding. Consider discontinuing 5 days before elective surgery. and then continue at 75mg PO daily. CONTRANDICATION Hypersensitivity to clopidogrel or any component of the formulation. Availability: Tablets: 75 mg NURSING RESPONSIBILITIES -Instruct patient to notify prescriber if unusual bleeding or bruising occurs. ST elevation MI (STEMI). DOSAGE AND AVAILABILITY Clopidogrel tablets. including those managed medically and those who are to be vention or coronary artery bypass graft. or peripheral arterial dse. Acute coronary syndrome without ST.GENERIC NAME CLASSIFICATION Miscellaneous cardiovascular drugs INDICATION Prevention of vascular ischemicevents in patients with symptomatic atherosclerosis. Adults: start therapy with a single 300-mg PO loading dose. daily.O. . Cases of thrombotic thrombocytopenic purpura (usually occurring within the first 2 weeks of therapy) have been reported. MI. . coagulation disorders. including patients with peptic ulcer disease. skin rash or itching. which prevent fibrinogen binding at that site and thereby reduce the possibility of platelet adhesion and aggregation. active pathological bleeding such asPUD or intracranial hemorrhage. -Inform patient that drug may be taken without regard to mass. Use with caution in patients with severe liver disease (experience is limited). SIDE EFFECTS Black. Use caution in mixing with other antiplatelet drugs. . -Platelet aggregation won t return to normal for at least 5 days after drug has been stopped. blood from vomiting.Reduce atherosclerotic events in patients with atherosclerosis documented by recent stroke. nosebleed. red or purple spots on the skin. stomach pain. or surgery.segment elevation (NSTEMI).

vasoconstriction. Observe patient closely for adverse reaction. small doses can cause vasodilation via beta2-vascular receptors. prn.000 solution IM or subcutaneous: 0. and cardiac arrest. hypertension. dizziness.000/kg subcutaneously.25mL of 1:1. Availability: Aerosol inhaler: 220 mcg/metered spray Injection: 0.01 ml of 1:1. eye pain. nausea. -Discard solution if reddishbrown and after expirationdate. dilates the pupil by contracting the dilator muscle. cardiac stimulation. drug increases rigidity and tremor. decreased renal and splanchnic blood flow. increased myocardial oxygen consumption. headache.01 mg/ml Nebulizer inhaler:1% (1:100) Parenteral: 5mg/m NURSING RESPONSIBILITIES In patients with Parkinson s disease. repeat q 20 minutes to 4 hours. anxiety. angina.5mL of 1:1. and beta2adrenergic receptors resulting in relaxation of smooth muscle of the bronchial tree. angleclosure glaucoma. management of open-angle (chronic simple) glaucoma. and decrease toxicity of the local anesthetic. dry throat. trembling. Epifrin [DSC]. Drug interferes with test for urinary cathecolamines. and dilation of skeletal muscle vasculature. added to local anesthetics to decrease systemic absorption. EpiPenJr. CONTRANDICATION Hypersensitivity to epinephrine or any component of the formulation. vomiting. chest pain. nervousness. wheezing. -Do not use topical preparation in children under 6 years of age. cardiac arrhythmias.1-0.GENERIC NAME CLASSIFICATION Antihistamine INDICATION Treatment of bronchospasms. large doses may produce constriction of skeletal and vascular smooth muscle. insomnia. ocular irritation. decreases production of aqueous humor and increase aqueous outflow. restlessness. increase duration of action. pallor. cardiac arrhythmia. DOSAGE AND AVAILABILITY Dosage Adult: 0. weakness. . Briskly massage site o SC or IM injection to hasten drug action. allergic lid reaction. acute urinary retention in patients with bladder outflow obstruction. SIDE EFFECTS Flushing. EpiPen. anaphylactic reactions.000 solution IV slowly over 5-10 minutes Children: 0.Primat ene Mist [OTC]) SPECIAL PRECAUTION Use cautiously in patients with long standing bronchial asthma or emphysema who have developed degenerative heart disease. lightheadedness. dyspnea.10. beta1-. EPINEPHRINE (Adrenalin. ACTION Stimulates alpha-. xerostomia.

Chemical similarities are present among sulfonamides. and reversible increases in BUN and creatinine. sulfonylureas. Close medical supervision of aggressive diuresis required. azotemia. thiazides. CONTRANDICATION Hypersensitivity to furosemide. excessive doses. avoid electrolyte and acid/base imbalances that might lead to hepatic encephalopathy. . sodium. Monitor fluid status and renal function in an attempt to prevent oliguria. anuria. alone or in combination with antihypertensive in treatment of hypertension.GENERIC NAME CLASSIFICATION Diuretics INDICATION Management of edema associated with congestive heart failure and hepatic or renal disease. fever GU: Nocturia. dizziness. In cirrhosis. FUROSEMIDE (Lasix) SPECIAL PRECAUTION Ototoxicity is associated with rapid I.5-2mg/kg PO once/twice daily NURSING RESPONSIBILITIES Adjust dose to avoid dehydration. renal impairment. magnesium. polyuria. ACTION Inhibits reabsorption of sodium and chloride in the ascending loop of Henle and distal renal tubule. Monitor closely for electrolyte imbalances particularly hypokalemia. administration. Hypersensitivity reactions can rarely occur. or any components of sulfonylureas. and loop diuretics (except ethacrynic acid). patients with hepatic coma or in states of severe electrolyte depletion until the condition improves or is corrected. interfering with the chloridebinding transport system. frequent urination Musculoskeletal : Muscle spasm DOSAGE AND AVAILABILITY Dosage Adult: 40mg IV injected slowly 1-2 minutes : 40 mg bid Children: 0. SIDE EFFECTS CNS: Vertigo. headache. carbonic anhydrase inhibitors.V. and calcium. chloride. and concurrent use of other ototoxins. thus causing increased excretion of water.

anorexia GU: Urine retention. ACTION Stimulates alpha2adrenoceptors in the brain stem. thus activating an inhibitory neuron. sicksinus syndrome. Patients should be instructed about the abrupt discontinuation (causes rapid increase in BP and symptoms of sympathetic overactivity). CONTRANDICATION Hypersensitivity to clonidine hydrochloride or any component of the formulation. mild to moderate hypertension: 75-150µg bid. Severe hypertension: Increase single dose to 300µg NURSING RESPONSIBILITIES Gradual withdrawal is needed (over 1 week for oral. producing a decrease in peripheral resistance. epidural clonidine may produce pain relief at spinal presynaptic and postjunctional alpha2adrenoceptors by preventing pain signal transmission. impotence Metabolic: Weight gain Others: Loss of libido DOSAGE AND AVAILABILITY Dosage Tab. 2-4 days with epidural) if drug needs to be stopped. Impairment of ability to drive or operate machinery. malaise GI: Constipation. . sedation. fatigue. CLONIDINE (Catapres. and blood pressure. resulting in reduced sympathetic outflow from the CNS. weakness. the pheochromocytoma form. Sudden discontinuance.GENERIC NAME CLASSIFICATION Antihypertensive INDICATION Hypertension of any etiology. pain relief occurs only for the body regions innervated by the spinal segments where analgesic contraindications of clonidine exist. dry mouth. Melzin) SPECIAL PRECAUTION Diseases affecting rhythmic and AV conduction system of the heart. SIDE EFFECTS CNS: Drowsiness. heart rate. renal failure.

dependent RNA polymerase. dizziness Respiratory: Dyspnea. Neisseria meningitides carrier. Children age 5 and up: 10-20 mg/kg PO or in IV daily in single dose. infection caused by gm+ve. Availability: Capsules: 150 mg. 300 mg Ruder for injection: 600 mg NURSING RESPONSIBILITIES Observe for hyperbilirubinemia. gm-ve bacteria other sensitive microorganisms. leprosy. chronic alcoholism. jaundice SIDE EFFECTS CNS: Headache. wheezing Skin: Pruritus. impaired liver or kidney function or patients taking other potentially hepatoxic agents. discontinue therapy if this. CONTRANDICATION Hypersensitivity. ACTION Inhibits bacterial RNA synthesis by binding to the beta subunit of DNA. in conjunction with clinical symptoms or signs of significant hepatocellular damage develop.GENERIC NAME CLASSIFICATION Antituberculosis INDICATION Pulmonary and extrapulmonary TB. rash DOSAGE AND AVAILABILITY Dosage: Adults: 10mg/kg Po or IV daily in single dos. . blocking RNA transcription. RIFAMPICIN (Rifadin) SPECIAL PRECAUTION Patients suffering from convulsive disorders.

a potent vasoconstrictor. Hematologic: Bone marrow depression Skin: Rash DOSAGE AND AVAILABILITY Dosage 1 tab daily may be increased to 2 tabs daily. history of angioneuro SIDE EFFECTS CNS: Asthenia. renal impairment. fatigue CV: Hypotension. if possible. abdominal pain. prevents conversion of angiotensin 1 to angiotensin 2. pectoris GI: Diarrhea. patients receiving lactulose and an oral anti-infective agent should be monitored for possible inadequate response to lactulose.GENERIC NAME CLASSIFICATION Antihypertensive INDICATION Hypertension in patients for whom combination therapy is appropriate. headache. nausea. aortic stenosis orhypertrophic cardiomyopathy. NURSING RESPONSIBILITIES Monitor periodically for electrolytes imbalance when lactulose is used >6 months or in patients predisposed to electrolyte abnormalities (e. elderly). ACTION Competitive inhibitor of angiotensinconverting enzyme (ACE). Vol-depleted or salt depletion. preexisting renal disease. vomiting GU: Decreased renal function. for 23 days to minimize symptomatic hypotension. . ENALAPRIL (Co-Renitec. Discontinue prior diuretic therapy. CONTRANDICATION Anuria..g. dizziness. angina. results in lower level of angiotensin 2 which causes an I increase in plasma renin activity and a reduction in aldosterone secretion. ischemic heart or cerebrovascular disease. chest pain. Vasotec) SPECIAL PRECAUTION Symptomatic hypotension. bilateral renal artery stenosis of the artery to a solitary kidney.

Deterioration in renal function can occur with initiation. they do not affect the response to bradykinin. angioedema. myalgia. losartan blocks the vasoconstrictor and aldosterone secreting effects of angiotensin II. and are less likely to be associated with nonreninangiostenin effects (eg. dose adjustment may beneeded. Use orthostatic effects. migraine. angiotensin II receptor antagonist may induce a more complete inhibition of the renin. Severe renal or hepatic impairment. may increase to 100 mg once daily. increases excretion of chloride. SIDE EFFECTS Dizziness. urticarial. significant aortic/mitral stenosis. pruritus. DOSAGE AND AVAILABILITY Dosage Initial and maintenance dose: 50 mg once daily. correct depletion first. uric acid. magnesium. Intravascular vol depletion. Children. Use caution with hepatic dysfunction. dose related rioration in renal function can occur with initiation. hepatitis. lactation. Cirrhosis and hepatic impairment. cough and angioedema). NURSING RESPONSIBILITIES Avoid use or use a smaller dose in patients who are volume depleted.GENERIC NAME CLASSIFICATION Antihypertensive INDICATION Hypertension ACTION As a selective and competitive. calcium and phosphate. hypersensitivity to other sulfonamide derived drugs. liver function abnormalities. nonpeptide angiotensin II receptor antagonist. Losartan increases urinary flow rate and in addition to being natriuretic and kaliuretic. . Hyzaar. Use with caution in unilateral renal artery stenosis and pre-existing renal insufficiency. CONTRANDICATION Anuria. Hyzaar DS) SPECIAL PRECAUTION Intravascular vol depletion.angiotensin system than ACE inhibitors. rashes. Pregnancy. LOSARTAN (Cozaar. Bilateral renal artery stenosis or stenosis of the artery to a solitary kidney.

predisposition to seizures. treatment of schizophrenia. control of nausea and vomiting. bone marrow suppression or subcorneal damage. hepatic.use with caution in patients at risk of aspiration pneumonia. CONTRANDICATION Contraindicated in patients hypersensitive to drugs. . CHLORPHOMAZINE (Thorazine) SPECIAL PRECAUTION Use cautiously in elderly or debilitated patients with hepatic or renal disease. 25mg IM Children ages 6 months and older: 0. SIDE EFFECTS Contraindicated in patients hypersensitive to drugs. severe cardiac. and in those in come. NURSING RESPONSIBILITIES Use with caution in Parkinson s disease. ACTION Chlorphomazine is an alphatic phenothiazine antipsychotic which blocks postsynaptic mesolimbic dopaminergic receptors in the brain. Esophageal dysmotility and aspiration have been associated with antipsychotic use. bone marrow suppression or subcorneal damage. exhibits a strong alphaadrenergic blocking effects and depresses the release of hypothalamic and hypophyseal hormones.55mg/kg PO q4-6h or IM q68hhours. believed to depress the reticular activating system. and in those in come. relief of restlessness and apprehension before surgery. vasomotor tone and emesis. severe or disease. to those with CNS depression. subcortical brain damage. glaucoma or prostatic hyperplasia. body temperature. bone marrow suppression. respiratory disorders. to those with CNS depression. hycalcema. thus effecting basal metabolism. Caution in patients hemodynamic instability.GENERIC NAME CLASSIFICATION Antipsychotics INDICATION Control of mania. DOSAGE AND AVAILABILITY Dosage Adult: For hospitalized patient with acute disease. renal or respiratory disease. wakefulness.

epilepsy. Parkinson s disease. CV effects. depresses the release of hypothalamic and hypophyseal hormones. . elderly. thyrotoxicosis. believed to depress the reticular activating system thus affecting basal metabolism. severe CNS depression. other CNS effects. Patients receiving combined therapy must be closely monitored. vasomotor tone. SIDE EFFECTS Extrapyramidal syndrome. DOSAGE AND AVAILABILITY Dosage 1->200mg/day depending on the condition and individuals responses. pregnancy.GENERIC NAME CLASSIFICATION Antipsychotics INDICATION -Psychotic disorders -Chronic psychosis requiring prolonged therapy -Nonpsychotic behavior disorder -Towette syndrome -Delirium ACTION Haloperidol is a butyrophenone antipsychotic which blocks postsynaptic mesolimbic dopaminergic D1and D2 receptors in the brain. HALOPERIDOL (Haldol. patients with lesions of the basal ganglia. neuroleptic malignant syndrome. NURSING RESPONSIBILITIES -Protect drug from light. lactation. emesis. use of lithium salts with high dose of haloperidol. body temperature. wakefulness. -Don t withdraw drug abruptly unless required by severe adverse reaction -Tell patient to relieve dry mouth with sugarless gum or hard candy. debilitated CONTRANDICATION Comatose condition. tardive dyskinesia. Serenace) SPECIAL PRECAUTION Hyperthyroidism.

urinary retention. 21mg PO bid or qid Children age 6 months and up: 1-2. UL Diazepam. . including the limbic system. reticular formation. hepatic. amnesia dependence.GENERIC NAME CLASSIFICATION Anxiolytics INDICATION Anxiety and tensions. slurred speech. myasthenia gravis. blurred vision. neonates. elderly. Halluconosis. 1st trimester of pregnancy. CV. -Monitor period hepatic. Trazepam.5mg Po tid or qid. DIAZEPAM (Anxionil. LBS Diazepam. Tremor. renal disease. Muscle Spasm ACTION Binds to stereospecific benzodiazepine receptors on the postsynaptic GABA neuron at several sites within the central nervous system. dilute dose just before giving. DOSAGE AND AVAILABILITY Dosage Adults: Depending on the severity. Nixtensyn. hypotension. SIDE EFFECTS Mental disturbance. hematopoietic function in patients receiving repeated or prolonged therapy. increase gradually as needed and a tolerated. lactation. renal. Valium) SPECIAL PRECAUTION Pregnancy. NURSING RESPONSIBILITIES -When using oral solution. depression. Agitation. blood dyscrasias CONTRANDICATION Severe psychoses. drowsiness. rash. Enhancement of the inhibitory effect of GABA in neural excitability results by increased neural membrane permeability to chloride ins result in hyperpolarization (a less excitable state) and stabilization. acute narrow-angle glaucoma. epileptics.

Reye syndrome DOSAGE AND AVAILABILITY Dosage Adult: Initially.4-3. Vitamin K deficiency and severe hepatic impairment. NURSING RESPONSIBILITIES -Use liquid form for children and patients who have difficulty in swallowing. adjunctive therapy in revascularization procedures (coronary artery bypass graft [CABG]. hearing loss GI: Nausea. St. carotid endarterectomy). blocks prostaglandin synthetizes action which prevents formation of the platelet-aggregating substance thromboxane A2 ASPIRIN (Bayer Aspirin Regimen Adult Low Strength [OTC]. asthma. do not use in children (<16 years old) for viral infections (chickenpox or flu symptoms). due to a potential association with Reye s syndrome. Bayer® Extra Strength Arthritis Pain Regimen. Joseph® Adult Aspirin. rhinitis. management of rheumatoid fever. or any components of the formulation. osteoarthritis. Sureprin 81TM [OTC]. . Easprin®. prophylaxis of stroke and/or transient ischemic episodes. stent implantation ACTION Inhibits prostaglandin synthesis. may be used as prophylaxis of myocardial infection. and gout (high dose). Bufferin®. Bayer® Plus Extra Strength [OTC]. percutaneous transluminal coronary angioplasty [PTCA]. Buffinol Extra.6g PO daily in divided doses. Ecotrin® Maximum Strength [OTC]. prn. Adults and Children older than 11 yrs. Old: 325-650mg PO or PR q4h. nasal polyps. Ecotrin® Low Strength [OTC]. Bayer® Women s Aspirin Plus Calcium [OTC]. acts on the hypothalamus heatregulating center to reduce fever. bruising. Buffinol [OTC]. do not exceed 5 doses in 24 hours. Bayer® Aspirin Regimen Regular Strength. hypothrombinomia. Hepatic: Hepatitis Skin: Rash.GENERIC NAME CLASSIFICATION Nonopioid analgesics and antipyretics INDICATION Treatment of mild-tomoderate pain. dyspepsia. Bayer® Aspirin Regimen Children s [OTC]. urticarial Other: Angioedema. -Advise parents that drug is only for short-term use. pregnancy 93rd trimester especially) SIDE EFFECTS EENT: tinnitus. ZORprin® SPECIAL PRECAUTION Use cautiously in patients with GI lesions. inherited or acquired bleeding disorders (including factor VII and Factor IX deficiency). inflammation and fever. 2. Halfprin. -In children. Bufferin® Extra Strength . Ecotrin® [OTC]. CONTRANDICATION Hypersensitivity to salicylates other NSAIDs. impaired renal function. with or without fever.

SPECIAL PRECAUTION Use cautiously with pregnant. Children: Initially. contractures such as cicatrical structures and Dupuytren sSyndr rome. or 20.GENERIC NAME CLASSIFICATION Anticoagulants INDICATION Hypertropic and keloidal scars. ACTION Accelerates formation of amhthrombin IIthrombin comlex and deactivates tthrombin. preventing conversion of fibrinogen to fibrin.000 units by IV bolus. rotating injection site.000units/m2 daily by IV infusion pumps. -Give the drug subcutaneously in fatty tissue. then 25units/kg/hr. movement restricting and disfiguring scars. CONTRANDICATION Hypersensitivity to parabens SIDE EFFECTS Rarely local skin reaction HEPARIN (Contractubex) DOSAGE AND AVAILABILITY Dosage Adult: Initially 5. then 7501500 units/hr. NURSING RESPONSIBILITIES -Monitor renal function periodically and stop drug in patients who develop unstable renal function or severe renal impairment while receiving therapy. 50 units/kg IV. women older than 60 years old are high risk for hemorrhaging. by IV infusion with pump. .

ACTION Exact mechanism is not understood. initiate dose at 100mg/day and increase weekly to recommended dosage. -Insulin . to reduce the possibility of acute gouty attacks.000mg PO with evening abdominal divided doses bloating. nausea. 500-1. Recurrent calcium oxalate stones: 200-300mg/day in single or divided doses. METFORMIN SPECIAL PRECAUTION Use caution when giving drug to elderly debilitated or malnourished CONTRANDICATION Contraindicated in patients hypersensitivity to drug and in those with hepatic DOSAGE AND AVAILABILITY GI: Dosage Diarrhea. Adults age 17 and up: vomiting. anorexia. Children >10 years Hematologic: Megaloblastic and adults: Secondary hyperuricemia associated with chemotherapy: 600-800mg/day in 2-3 divided doses for prevention of acute uric acid nephropathy for 2-3 days starting 12 days before chemotherapy. Initially. possibly increases. SIDE EFFECTS NURSING RESPONSIBILITIES -Don t mix drug in a syringe with any other insulin except NPH.GENERIC NAME CLASSIFICATION Antidiabetics and glucagons INDICATION Adjunct to diet to lower blood glucose with type 2 diabetes mellitus. Gout: Mild: 200-300mg/day Gout: Severe: 400-600mh/day.

ACTION Chemical effect: Reduce uric acid production by inhibiting the necessary biochemical reaction Therapeutic effect: Alleviates Gout symptoms. urticarial and pulp uric lesions. SIDE EFFECTS Side effects: Headache. Zyloprim) SPECIAL PRECAUTION In pregnant and Breast feeding women use cautiously. and psoriasis. ApoAllopurinol.Give drug with or immediately after meals to minimize adverse GI reactions. Hyperuricemias secondary to malignancies. nausea. severe gout with large tophi. 800 mg daily. erythema multiform.Assess patient s history. .have patients drink plenty of fluids while taking drug. CONTRANDICATION Contraindicated in patients hypersensitive to drug or any of its components. ichthyoids. multiple myeloma. Recurrent calcium oxalate calculi.GENERIC NAME CLASSIFICATION Antigout drug INDICATION Gout To prevent acute gouty attacks. Rash. polycythemia Vera. diarrhea. retinopathy. 2000. Capurate. uremia. toxic epidermal necrosis DOSAGE AND AVAILABILITY Dosage: Adults: mild gout. Availability: Capsules: 100 mg. doses larger than 300mg should be divided. Such as acute or chronic leukemia.agranulocyt osis. vomiting. severe furunculosis of nose Adverse Reaction: Renal failure. anemia. drowsiness. abdominal pain. aplastic anemia. mg 300 mg Allopurinol sodium Injection: 500m/30ml vial NURSING RESPONSIBILITIES . unless contraindicated. . Thrombocytopenia. exfoliated lesions. 200 to 300 mg PO daily. . 300 mg Tablets: 100 mg. Hepatitis. ALLOPURINOL (Allorin. . Gout may be secondary to dose.be alert for adverse reactions and drug interactions. . cataracts. Maximum dosage. 400 to 600 mg PO daily. pruritus. Dosage varies with severity of dose and can be given as single dose or in divided doses.Advise patient not to take alcohol while taking drug.

instruct patient to report hearing loss.Obtain specimen for culture and sensitivity test before first dose except when treating tuberculosis. DOSAGE AND AVAILABILITY Dosage: Adults: 1g IM q 12 Hours for 1 week.Enterococcus endocarditis.Tularemia ACTION Chemical effect: Inhibits protein synthesis by binding directly to 30S ribosomal subunit. . In breastfeeding women and elderly. . eosinophilia. hypersensitivity reaction. . Start therapy pending test result. exfoliated dermatitis.GENERIC NAME CLASSIFICATION Antibiotic INDICATION -Streptococcal endocarditis. or fullness in ears and dizziness immediately. nephrotoxicity leukopenia. CONTRANDICATION Use cautiously in patients with impaired kidney function or neuromuscular dose. . and regularly thereafter to monitor the drug s effectiveness. Adverse effect: Neuromuscular blockade. Therapeutic effect: Kills Bacteria STREPTOMYCIN SPECIAL PRECAUTION Use cautiously in patients with impaired kidney function or neuromuscular dose. and then 500 mg q 12 hours for 1 week. apnea. anaphylaxis. angioedema. -protect hands while preparing the drug because drug is irritating.Primary and adjunct treatment in tuberculosis. vomiting. SIDE EFFECTS Side Effects: Ototoxicity.5-ml ampules NURSING RESPONSIBILITIES -Assess patient s infection before starting therapy. Availability: Injection: 400mg/ml. given with penicillin. Thrombocytopenia. . 1 g/2. roaring noises. . use cautiously. use cautiously.Be alert for adverse reactions and drug interactions. . In breastfeeding women and elderly. nausea.

. Controlled-Release: 15 mg. -Help client practice cough and deepbreathing exercises and incentive spirometer to decrease risk of atelectasis. MORPHINE SULFATE (Avinza. 30 mg. NURSING RESPONSIBILITIES . Monitor VS and respiratory status.GENERIC NAME CLASSIFICATION Narcotic Analgesic INDICATION -relief of moderate to severe pain -preoperatively for sedation and to reduce apprehension -supplement to anesthesia -control postoperative pain ACTION Decreased permeability of the cell membrane to sodium. 100 mg Injection: 0.5 mg/mL. at the lowest dosage level that will achieve adequate analgesia Availability: Capsules. Infumorph 200 and 500. 30 mg. constipation. . outcome. 50 mg. headache DOSAGE AND AVAILABILITY Dosage: Oral solution. Tablets. somnolence. Oramorph SR) SPECIAL PRECAUTION -clients with known seizure disorders -use with extreme caution in aged or debilitated clients CONTRANDICATION -Heart failure secondary to chronic lung disease -cardiac arrhythmias -brain tumor -acute alcoholism -delirium tremens -convulsive states -cardiac arrhythmias -pregnancy category C SIDE EFFECTS N&V. Astramorph PF. to 50 mg/mL Tablets. 60 mg.Note any seizure disorder or head trauma. which results in diminished transmission of pain impulses and therefore analgesia. Soluble 5 30 mg (solution or tablets) on a regularly scheduled basis q 4 hr. Tablets.List other agents prescribed. ExtendedCapsules. Duramorph. Sustained-Release Pellets: 20 mg.

V.contraindicated in patients hypersensitive to methylergonovine or any component of the formulation. palpitation CNS: Hallucinations. after delivery of placenta. CONTRANDICATION . azole antifungals. Nursing mothers. and some macrolide antibiotics). pregnancy SIDE EFFECTS Cardiovascular: hypertension. hypertension.GENERIC NAME CLASSIFICATION PC: Ergot Alkaloid and Derivative TC: oxytocic. Obliterative vascular disorders. -ergot alkaloids are contraindicated with potent inhibitors of CYP3A4 (includes protease inhibitors. I. vomiting. As a last resort. or during puerperium. slowly over several minutes and monitor blood pressure closely. temporary chest pain. Hepatic or renal disease. use may induce sudden hypertension and cerebrovascular accidents. .2 mg after delivery of anterior shoulder. give I. dizziness. may be repeated as required at intervals of 2-4 hours NURSING RESPONSIBILITIES -Be alert for adverse reactions and drug interactions. -This drug should be used extremely carefully because of its potent vasoconstrictor action. lactation stimulant INDICATION Prevention and treatment of postpartum and post abortion hemorrhage caused by uterine atony or sub involution ACTION Stimulates uterine smooth muscles producing sustained contractions thereby shortens the third stage of labor METHERGINE (methylergonovine maleate) SPECIAL PRECAUTION Sepsis.V. diarrhea. seizure. toxemia. nasal congestion Miscellaneous: Diaphoresis DOSAGE AND AVAILABILITY Dosage: IV: 0. 2nd stage of labor. headache Gastrointestinal: Nausea. foul taste Local: Thrombophlebitis Optic: Tinnitus Renal: Hematuria Respiratory: Dyspnea.

Rash.Osteoarthritis SPECIAL PRECAUTION Use cautiously in patients with history of chronic alcohol abuse because hepatoxicity may occur after therapeutic doses.Give liquid form tochildren and otherpatients who havetrouble swallowing . hypoglycemia. Maximum. by inhibiting prostaglandin or pain receptor sensitizers. CONTRANDICATION Contraindicated in patients hypersensitive to drug. pancytopenia.assess patient s pain or temperature before and during therapy.66ml Sprinkles: 80mg/capsules Suppositories: 80 mg. neutropenia. Acephen. Dymadon. Alternatively. 325 mg. 120 mg Tablets: 160 mg. 2 extended release caplets Po q 8 hours. ACTION Chemical effect: May produce analgesic effect by blocking pain impulses. Therapeutic effect: relieves pain and reduces fever. SIDE EFFECTS Side effects: Hemolytic anemia jaundice. Tempra.6 g daily unless monitored by prescriber. 4 g daily. urticaria Adverse Reaction: Thrombocytopenia. . 500 mg Tablets (chewable). liver damage. Availability: Infant drops: 80mg/0. In pregnant and breastfeeding women. Tylenol) . antipyretic INDICATION -Mild pain or fever. prn. leukopenia. DOSAGE AND AVAILABILITY Dosage: Adult and children older than age 12: 325 to 650 mg PO or PR q 4 hours prn or 1 g PO tid or qid. Aceta. Dosage for long term therapy shouldn t exceed 2. May relieve fever by acting in hypothalamic heat-regulating center. Panadol.be alert for adverse reactions and drug interactions .8 ml Capsules: 150 mg. PARACETAMOL ACETAMINOPHEN (Abenol. use cautiously.GENERIC NAME CLASSIFICATION Nonopioid analgesic. 80 mg. 160 mg NURSING RESPONSIBILITIES . Aceta-Elixir. 300 mg Injection: 600mg Solution: 80mg/1.

450 mg. .bulimia ACTION A decrease in cyclic AMP levels caused by lithium which decreases sensitivity of hormonalsensitive adenylcyclase receptors LITHIUM (Lithobid. Extended-Release: 300 mg. Lithonate. Tablets. Tablets. and ECG . severe bradycardia causing syncope. 600 mg. thirst. Lithotabs) SPECIAL PRECAUTION safety and efficacy have not been established for children less than 12years of age -use with caution in geriatric clients because lithium is more toxic to the CNS in these clients CONTRANDICATION -cardiovascular or renal dose. Capsules. urinalysis. kidney and thyroid function studies. polyuria.GENERIC NAME CLASSIFICATION Antimanic INDICATION -control of mania in manic-depressive clients . CV function. general discomfort Adverse Reaction: peripheral circulatory collapse. coma DOSAGE AND AVAILABILITY Dosage: Acute mania. Tablets. assess for decreased function. chemistry. weight. VS.premenstrual tension .2 grams/day in three doses Available forms: Lithium carbonate Capsules: 150 mg. Extended-release (Adults)300 600 mg 3 times per day or 600 900 mg twice per day of slow-release form (Elderly and debilitated clients) 0. -brain damage -lactation -pregnancy category D -dehydration . document antiinflammatory agent(s) used. Syrup.alcoholism accompanied by depression . thyroid function. 300 mg.clients receiving diuretics SIDE EFFECTS Side effects: Due to initial therapy: Fine hand tremor. Tablets: 300 mg. -With arthritic conditions.Document mental status.6 1. Lithium citrate Syrup: 300 mg/5 mL NURSING RESPONSIBILITIES -Monitor lithium levels. transient and mild nausea.tardive dyskinesia .

peritonitis .75% Tablets: 250 mg. MetroGel. NURSING RESPONSIBILITIES -Reduce dose in those with hepatic dose.Do not use syringes with Al needles or hubs.GENERIC NAME CLASSIFICATION Trichomonacide. strand breakage. resulting in loss of helical structure.75%.75%. flulike symptoms Adverse Reaction: seizures. Flagyl 375. 1% Injection: 5 mg/ 1 mL (ready-to-use) Injection.. amebicide INDICATION -serious infections due to susceptible anaerobic bacteria . ExtendedRelease: 750 mg Vaginal Gel/Jelly: 0. and cell death. bone marrow aplasia DOSAGE AND AVAILABILITY Dosage: Amebiasis: Acute amebic dysentery or amebic liver abscess Availability: Capsules: 375 mg Cream: 0.Monitor CBC.Document indications for therapy and symptom characteristics. Vandazole) SPECIAL PRECAUTION -use with caution in those with evidence or history of blood dyscrasias or in those with impaired hepatic function CONTRANDICATION -blood dyscrasias -active organic disease of the CNS . MetroLotion. Flagyl ER. . 1% Gel (Topical): 0. LFTs.V.trichomoniasis during the first trimester of pregnancy -lactation SIDE EFFECTS Side effects: Following systemic use: Headache. bacterial infection. METRONIDAZOLE (Flagyl I. . genital pruritus. inhibition of nucleic acid synthesis. Clostridium species and Peptococcusniger ACTION Inhibits growth of trichomonae and amoebae by binding to DNA. fragilis group. and cultures . . metallic taste. vaginitis.75 %. Lyophilized: 500 mg Lotion: 0. nausea. 500 mg Tablets.skin structure infections due to Bacteroidesspecies including B.

swallowed. thereby reducing their energy until death results. -Teach client to practice personal hygiene and wash hands regularly. and hookworm Tablets. -Tablets may be chewed.GENERIC NAME CLASSIFICATION Anthelmintic INDICATION -whipworm -pinworm -roundworm -common and American hookworm ACTION Blocks the glucose uptake of the organisms. diarrhea DOSAGE AND AVAILABILITY Dosage: Whipworm. onset and characteristics of S&S. one time Availability: Tablets. Chewable: (Adults and children) 1 tablet morning and evening on 3 consecutive days Pinworm 1 tablet. and any contributory factors. MEBENDAZOLE (Vermox) SPECIAL PRECAUTION --use with caution in children under 2 years old and during lactation CONTRANDICATION -hypersensitivity to mebendazole -pregnancy category C SIDE EFFECTS Side effects: Transient abdominal pain. or crushed with food. roundworm. Identify all persons in contact and potentially affected. Chewable 100 mg NURSING RESPONSIBILITIES -Note clinical confirmation of organism. .

Availability: Injection: 100 units/ml NURSING RESPONSIBILITIES -Note dose.GENERIC NAME CLASSIFICATION Insulin Product INDICATION -diabetic coma -diabetic acidosis -clients suffering from labile diabetes ACTION Increases synthesis of glycogen in the liver. outcome. Velosulin BR) SPECIAL PRECAUTION -a pregnant diabetic client inhibits milk production. INSULIN (REGULAR) (Humulin R. and U/A: micro albumin. Injection is given 1530 mi before meals and at bedtime. Onset. pruritus. Novolin R. exercise and weight control. -Tell client to report adverse effect or lack or sugar control. renal and LFTs. hypokalemia. . Previous agent s trialed. injection site reaction. rash DOSAGE AND AVAILABILITY Dosage: SC (Adults) 5-10 units (Pediatric) 2-4 units. CBC. CONTRANDICATION hypersensitivity to insulin SIDE EFFECTS Side effects: Hypoglycemia. Continue diet. -Monitor VS. HbA1c. level of control/ understanding of dose.

ACETHYLCYSTINE (Acetadote.GENERIC NAME CLASSIFICATION Mucolytic INDICATION -chronic emphysema -emphysema with bronchitis -tuberculosis -chronic asthmatic ACTION Reduces the viscosity of purulent and no purulent pulmonary secretions and facilitates their removal by splitting disulfide bonds. -After prolonged nebulization. N&V. -Note pulmonary findings: determine when spasm occur. . stomatitis DOSAGE AND AVAILABILITY Dosage: Direct instillation into tracheostomy 1-2 ml of 10% or 20% solution every 1-4 hours Closed tent or croquette Up to 300 ml of 10% or 20% solution per treatment. 20% NURSING RESPONSIBILITIES -Use nonreactive plastic.Pregnancy category B SIDE EFFECTS Side effects: Bronchial/tracheal irritation. Mucomyst) SPECIAL PRECAUTION -lactation -use with caution in elderly and clients with asthma CONTRANDICATION -sensitivity to drug . rash. or stainless steel for administration. dilute the last fourth of the medication with sterile water to prevent drug concentration. Availability: Injection: 20% Oral Solution (as sodium): 10%. glass.

paroxysmal supraventricular tachycardia. -Before administering initial loading dose. and hypomagnesemia may predispose to toxicity).6-1 mg (1015 mcg/kg) given as 50% of the dose initially and additional fractions given at 4-8 hr interval. ECG changes GI: anorexia. . diarrhea Endo:gynecomasti a Hemat: thrombocytopenia DOSAGE AND AVAILABILITY (IV)Adult:Digitilizing Dose I0. -Monitor blood pressure periodically in patients receiving IV dogoxin. slowing conduction through SA and AV nodes and providing Antiarrhythmic effect. (PO)Adult: Digitalizing dose 0. atrial fibrillation and flutter. Maintenance dose 0. Obese patients.75-1. and Lactation. -Oral preparations can be administered without regard to meals. CONTRANDICATION Hypersensitivity. Also acts on CNS to enhance vagal tone. constrictive pericarditis.Digitek.5 mg/day as gelatin capsules. Lanoxicaps) SPECIAL PRECAUTION Electrolyte abnormalities ( hypokalemia. idiopathic hypertrophic subaortic stenosis. uncontrolled ventricular arrhythmias. NURSING RESPONSIBILITIES -Monitor apical pulse before administering. headache. nausea.350-0. hypercalcemia. Therapeutic effect: strengthens myocardial tractions and slows conduction through SA and Av nodes. ACTION Chemical effect: Inhibits sodiumpotassiumactivated adenosine triphosphates. and serum level.Renal impairement. AV block. depending on patient s lean body weight. MI. antiarrythmic INDICATION -Heart failure. vomiting. determine whether patient has taken any digitalis preparations in the preceding 2-3 wk. -Observe patient for signs and symptoms of toxicity. yellow vision CV: Arrhythmias. known alcohol intolerance (elixir only) SIDE EFFECTS CNS: fatigue.Geriatric patients. -Monitor intake and output ratios and daily weights. Pregnancy.GENERIC NAME CLASSIFICATION Pharmacologic Class: Cardiac glycoside Therapeutic Class: Inotropic. bradycardia. LANOXIN (Digoxin. weakness EENT: blurred vision.063-0.25 mg (10-15 mg/kg) given as 50% of the dose initially and additional fractions given at 4-8 hr intervals. thereby promoting movement of calcium from extra cellular to intracellular cytoplasm and strengthening myocardial contraction.5 mg/day as tablets or 0. renal function.

Availability: Injection: 200 mg.Store vials for IV use from 5 30°C (41 86°F). Proquin XR) SPECIAL PRECAUTION -safety and effectiveness of ophthalmic. or IV use have not been determined in children -possible antibiotic resistance when used to treat Pseudomonas aeruginosa infections. and repair of bacterial DNA. colior Proteus mirabilis -UTI ACTION Interferes with DNA gyrase and topoisomerase IV. itching.Note reasons for therapy. N&V. 1. stinging. it may be taken with/without meals. after a meal. inflammation Adverse Reaction: Intestinal perforation. Streptococcus pneumoniae. fluoroquinolone INDICATION . 500 mg. . 400 mg Ophthalmic Ointment: 3. S&S and obtain cultures.000 mg once daily of extended-release tablets for 7 14 days. DNA gyrase is an enzyme needed for replication. 250 mg. recommended dosing time is 2 hr. rash After ophthalmic use: Irritation. Protect from light.Chronic bacterial prostatitis due to E. . transcription. PO.or Moraxella catarrhalis .acute sinusitis due to Haemophilus influenzae. diarrhea. burning. 750 mg Tablets. Cipro.Although food delays drug absorption. excessive heat. CONTRANDICATION -hypersensitivity to quinolones -use in children -lactation -Pregnancy category C SIDE EFFECTS Side effects: After systemic use: Headache. ExtendedRelease: 500 mg. restlessness. and freezing .000 mg NURSING RESPONSIBILITIES . CIPROILOXACIN (Ciloxan Ophthalmic.33 mg/g (equivalent to 3 mg base) Tablets: 100 mg. acute uncomplicated Adults: 1. toxic epidermal necrolysis DOSAGE AND AVAILABILITY Dosage: Pyelonephritis.GENERIC NAME CLASSIFICATION Antibiotic.

constipation/ diarrhea. drowsiness. gingival hyperplasia Adverse Reaction: increased seizures. characteristics of S&S.GENERIC NAME CLASSIFICATION Antiarrhythmic. bioavailability of phenytoin may vary. toxic hepatitis DOSAGE AND AVAILABILITY Dosage: Oral suspension. slurred speech. . severe myocardial insufficiency) CONTRANDICATION -hypersensitivity to hydantoins . . N&V.heart disease (hypotension. clinical presentation. hydantoin INDICATION -Chronic epilepsy . PHENYTOIN (Dilantin Infatab.Note history and nature of seizures. intermittent porphyria clients with a history of asthma or other allergies . causes/characteristi cs. Class IB Anticonvulsant.Do not substitute products or exchange brands. frequency. addressing location. . other agents trialed.control seizures during neurosurgery . duration.Lactation -Pregnancy category C SIDE EFFECTS Side effects: Ataxia. outcome. Chewable: 50 mg Oral Suspension: 125 mg/5 m NURSING RESPONSIBILITIES .Severe preeclampsia ACTION Acts in the motor cortex of the brain to reduce the spread of electrical discharges from the rapidly firing epileptic foci in this area. Chewable (Adults.exfoliative dermatitis . confusion. Tablets.impaired renal or hepatic function . toxic epidermal necrolysis. Dilantin-125) SPECIAL PRECAUTION -acute. onset.to 10-day intervals until seizures are controlled (Pediatric. adjust dos age at 7. initial) 5 mg/kg/day in two to three divided doses Availability: Tablets.List reasons for therapy. triggers and EEG findings.sinus bradycardia . rash. initial) 100 mg (125 mg of the suspension) 3 times per day. blood levels.

Sign up to vote on this title
UsefulNot useful